Deborah Dillon
Impact in
- Oncology top 2%
- Cancer Cells and Metastasis
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
Papers in
- Oncology 39
- Cancer Immunotherapy and Biomarkers 10
- HER2/EGFR in Cancer Research 8
- Cancer Cells and Metastasis 7
-
- Cancer Genomics and Diagnostics 17
- Breast Cancer Treatment Studies 14
- Co-authors
- Lili Ji (2 shared papers)Kathleen A. Curtis (2 shared papers)David L. Rimm (3 shared papers)Eric R. Fearon (2 shared papers)José Costa (6 shared papers)Andrea L. Richardson (5 shared papers)Eric P. Winer (22 shared papers)Judy E. Garber (6 shared papers)
- Journals
- Cancer Research (11 papers)Journal of Clinical Oncology (8 papers)Proceedings of the National Academy of Sciences (5 papers)Archives of Pathology & Laboratory Medicine (4 papers)npj Breast Cancer (4 papers)
- Partner nations
- United StatesBrazilItaly
In The Last Decade
Deborah Dillon
85 papers receiving 3.7k citations
Deborah Dillon's Hit Papers
Peers
Comparison fields: 5 of 129
- Oncology 1.3k
- Cancer Research 678
- Pathology and Forensic Medicine 431
- Molecular Biology 1.3k
- Rehabilitation 111
Countries citing papers authored by Deborah Dillon
This map shows the geographic impact of Deborah Dillon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dillon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dillon more than expected).
Fields of papers citing papers by Deborah Dillon
This network shows the impact of papers produced by Deborah Dillon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dillon. The network helps show where Deborah Dillon may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah Dillon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 212 | |
| 2 | 2014 | 197 | |
| 3 | STING agonism reprograms tumor-associated macrophages and overcomes resistance to PARP inhibition in BRCA1-deficient models of breast cancer Hit paper breakdown → | 2022 | 181 |
| 4 | 1998 | 176 | |
| 5 | 1990 | 176 | |
| 6 | 2020 | 173 | |
| 7 | 2014 | 155 | |
| 8 | 2020 | 148 | |
| 9 | 2013 | 134 | |
| 10 | 2013 | 126 | |
| 11 | 1985 | 125 | |
| 12 | 2012 | 123 | |
| 13 | 2020 | 115 | |
| 14 | 2017 | 114 | |
| 15 | 2002 | 110 | |
| 16 | 2010 | 108 | |
| 17 | 2005 | 86 | |
| 18 | The expression of p120ctn protein in breast cancer is independent of alpha- and beta-catenin and E-cadherin. | 1998 | 73 |
| 19 | 1991 | 68 | |
| 20 | 2020 | 59 |
About Deborah Dillon
Deborah Dillon is a scholar working on Oncology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 88 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (17 papers), Breast Cancer Treatment Studies (14 papers), Cancer Immunotherapy and Biomarkers (10 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Cells and Metastasis (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Advanced Breast Cancer Therapies (6 papers) and Breast Lesions and Carcinomas (6 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (678 citations), Pathology and Forensic Medicine (431 citations), Molecular Biology (1.3k citations) and Rehabilitation (111 citations). Deborah Dillon has collaborated with scholars based in United States, Brazil and Italy. Frequent co-authors include Lili Ji, Kathleen A. Curtis, David L. Rimm, Eric R. Fearon, José Costa, Andrea L. Richardson, Eric P. Winer, Judy E. Garber, Rola A.D. Ghoussoub and Eric B. Rimm. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Archives of Pathology & Laboratory Medicine and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.